What is Nucelis?
Nucelis operates at the intersection of advanced genetics and sustainable agriculture, leveraging its Rapid Trait Development System (RTDS) to pioneer precision gene editing. By focusing on the development of non-transgenic plant traits, the company provides a sophisticated alternative to traditional breeding methods. This approach enables the creation of crops that exhibit enhanced productivity and resilience, effectively reducing the reliance on chemical inputs. By facilitating the production of sustainable ingredients, Nucelis is actively positioning itself as a critical partner for global corporations seeking to transition away from fossil fuel-based components and lower their overall greenhouse gas emissions footprint.
How much funding has Nucelis raised?
Nucelis has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nucelis
PPP
Public-Private Partnership
What's next for Nucelis?
With the recent influx of capital, Nucelis is well-positioned to scale its operational capacity and accelerate the commercialization of its gene-edited trait portfolio. The company is expected to prioritize the expansion of its RTDS platform, targeting broader applications across diverse crop varieties to meet the growing demand for sustainable agricultural solutions. Strategic focus will likely shift toward deepening partnerships with major food and ingredient manufacturers, ensuring that their non-transgenic innovations are integrated into global supply chains. As the regulatory environment for gene-edited products continues to evolve, Nucelis remains focused on maintaining its leadership in precision breeding, aiming to set new industry standards for yield optimization and environmental stewardship.
See full Nucelis company page
